Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study.

Mocroft A, Brettle R, Kirk O, Blaxhult A, Parkin JM, Antunes F, Francioli P, D'Arminio Monforte A, Fox Z, Lundgren JD; EuroSIDA study group.

AIDS. 2002 Aug 16;16(12):1663-71.

PMID:
12172088
3.

Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005.

Yang CH, Huang YF, Hsiao CF, Yeh YL, Liou HR, Hung CC, Yang SY.

HIV Med. 2008 Aug;9(7):535-43. doi: 10.1111/j.1468-1293.2008.00600.x. Epub 2008 Jun 28.

4.

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD; HIV Outpatient Study Investigators.

J Acquir Immune Defic Syndr. 2006 Sep;43(1):27-34.

PMID:
16878047
5.

Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort.

Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, Zilmer K, Vella S, Kirk O, Lundgren JD; EuroSIDA Group.

AIDS. 2005 Mar 24;19(6):593-601.

PMID:
15802978
6.

Do HIV disease progression and HAART response vary among injecting drug users in Europe?

van Asten L, Zangerle R, Hernández Aguado I, Boufassa F, Broers B, Brettle RP, Roy Robertson J, McMenamin J, Coutinho RA, Prins M.

Eur J Epidemiol. 2005;20(9):795-804.

PMID:
16170664
7.

Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City.

Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV.

Ann Intern Med. 2006 Sep 19;145(6):397-406.

PMID:
16983127
8.

Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.

Crum NF, Riffenburgh RH, Wegner S, Agan BK, Tasker SA, Spooner KM, Armstrong AW, Fraser S, Wallace MR; Triservice AIDS Clinical Consortium.

J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):194-200.

PMID:
16394852
9.

Risk factors and causes of death in the Australian HIV Observational Database.

Petoumenos K, Law MG; Australian HIV Observational Database.

Sex Health. 2006 May;3(2):103-12.

PMID:
16800396
10.

Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.

Katsarou O, Touloumi G, Antoniou A, Kouramba A, Hatzakis A, Karafoulidou A.

Haemophilia. 2005 Jul;11(4):360-5.

PMID:
16011588
11.

Mortality and morbidity of HIV infected patients receiving HAART: a cohort study.

Panos G, Samonis G, Alexiou VG, Kavarnou GA, Charatsis G, Falagas ME.

Curr HIV Res. 2008 May;6(3):257-60.

PMID:
18473789
12.

Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA study.

Mocroft A, Monforte Ad, Kirk O, Johnson MA, Friis-Moller N, Banhegyi D, Blaxhult A, Mulcahy F, Gatell JM, Lundgren JD; EuroSIDA study group.

HIV Med. 2004 Nov;5(6):437-47.

13.

Pre-AIDS mortality in HIV-infected individuals in England, Wales and Northern Ireland, 1982-1996.

Laurichesse HA, Mortimer J, Evans BG, Farrington CP.

AIDS. 1998 Apr 16;12(6):651-8.

PMID:
9583606
14.

Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.

Martínez E, Milinkovic A, Buira E, de Lazzari E, León A, Larrousse M, Loncá M, Laguno M, Blanco JL, Mallolas J, García F, Miró JM, Gatell JM.

HIV Med. 2007 May;8(4):251-8.

15.

Impact of hepatitis C infection on long-term mortality of injecting drug users from 1990 to 2002: differences before and after HAART.

Lumbreras B, Jarrín I, del Amo J, Pérez-Hoyos S, Muga R, García-de la Hera M, Ferreros I, Sanvisens A, Hurtado I, Hernández-Aguado I.

AIDS. 2006 Jan 2;20(1):111-6.

PMID:
16327326
16.

Changes in mortality following HIV and AIDS and estimation of the number of people living with diagnosed HIV/AIDS in Australia, 1981-2003.

Nakhaee F, Black D, Wand H, McDonald A, Law M.

Sex Health. 2009 Jun;6(2):129-34. doi: 10.1071/SH08007.

PMID:
19457292
17.

[Trends in mortality and causes of death among persons with HIV infection, 1985-2004].

Aldaz P, Castilla J, Moreno-Iribas C, Irisarri F, Floristán Y, Sola-Boneta J, Martínez-Artola V, Fernández-Jaúregui C, Dorronsoro I.

Enferm Infecc Microbiol Clin. 2007 Jan;25(1):5-10. Spanish.

PMID:
17261240
18.

CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.

Seminari E, De Silvestri A, Boschi A, Tinelli C.

AIDS Rev. 2008 Oct-Dec;10(4):236-44.

PMID:
19092979
19.

Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapy.

Mocroft A, Gatell J, Reiss P, Ledergerber B, Kirk O, Vella S, Blaxhult A, Phillips AN, Lundgren J; EuroSIDA study group.

AIDS. 2004 Nov 19;18(17):2333-7.

PMID:
15577550
20.

Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.

Cozzi-Lepri A, Phillips AN, Clotet B, Mocroft A, Ruiz L, Kirk O, Lazzarin A, Wiercinska-Drapalo A, Karlsson A, Lundgren JD; EuroSIDA Study Group.

AIDS. 2008 Oct 18;22(16):2187-98. doi: 10.1097/QAD.0b013e328310e04f.

PMID:
18832882
Items per page

Supplemental Content

Write to the Help Desk